Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2022-10-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
投资者关系管理制度（2022年10月）
Governance Information Classification · 95% confidence The document is titled '投资者关系管理制度' which translates to 'Investor Relations Management System'. It outlines the principles, responsibilities, and procedures for managing investor relations, including communication with investors, analysts, media, and regulatory compliance. It does not contain financial statements, earnings data, or audit information. It is a governance-related document detailing internal rules and practices for investor relations management. Therefore, it fits best under Governance Information (CGR). The document length is 6560 characters, indicating it is a full policy document rather than a brief announcement or notice.
2022-10-28 Chinese
独立董事关于第五届董事会第二十八次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the appointment of a company secretary at a board meeting. It references compliance with company bylaws and regulatory rules but does not contain financial data, audit results, or detailed management reports. It is related to board/management information, specifically about a management appointment. The document length is short and focused on governance and personnel matters, fitting the Board/Management Information category rather than a full report or announcement of voting results.
2022-10-28 Chinese
第五届监事会第二十六次（临时）会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding the approval of the company's 2022 third quarter report and a 100% acquisition of another company. It includes details about the meeting, attendance, and voting results. The document does not contain the actual financial statements or detailed financial data of the third quarter report but refers to the report being published elsewhere (on 巨潮资讯网). This indicates it is a meeting resolution or announcement rather than the report itself. The document also includes approval of a corporate acquisition, but the main content is the Supervisory Board's meeting resolution. This fits best under Regulatory Filings (RNS) as it is a formal announcement of meeting resolutions and approvals without the full report or detailed financial data included.
2022-10-26 Chinese
独立董事关于第五届董事会第二十七次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a specific board meeting item regarding the acquisition of 100% equity in another company. It references compliance with governance rules and company bylaws, and provides an independent judgment on the fairness and legality of the transaction. The content is focused on board-level approval and opinion rather than financial results, audit, or regulatory filings. It is not a full report, earnings release, or announcement of voting results. The document fits best under Board/Management Information (MANG) as it relates to board decisions and management-level disclosures about corporate actions.
2022-10-26 Chinese
关于收购深圳圣诺医疗设备股份有限公司100%股权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of 100% equity in Shenzhen Shengnuo Medical Equipment Co., Ltd. by Yingkang Life Technology Co., Ltd. It includes extensive information about the transaction, the parties involved, the approval process, financial data of the target company, and valuation methods. The content focuses on a corporate transaction involving acquisition and investment, with no indication of it being a full annual or interim financial report, earnings release, or other types of filings. The document is not a simple announcement of a report publication but a substantive disclosure of a capital transaction. Therefore, the filing type corresponds to Capital/Financing Update (CAP).
2022-10-26 Chinese
第五届董事会第二十七次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's 27th interim meeting of the 5th Board of Directors. It includes details about the meeting date, attendance, and voting results on two main agenda items: approval of the 2022 Q3 report and approval of an acquisition transaction. The document references the 2022 Q3 report and acquisition announcement as separately published on the official disclosure website, indicating this document itself is not the full quarterly report or acquisition announcement but a board meeting resolution announcement. The content focuses on board decisions and meeting procedures, which aligns with Board/Management Information filings. The document length is short (1482 characters), and it does not contain detailed financial statements or full report content, so it is not an Interim/Quarterly Report or Annual Report. Therefore, the correct classification is Board/Management Information (MANG).
2022-10-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.